R
Ronald F van Vollenhoven
Researcher at University of Amsterdam
Publications - 354
Citations - 32567
Ronald F van Vollenhoven is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 72, co-authored 309 publications receiving 26884 citations. Previous affiliations of Ronald F van Vollenhoven include Karolinska Institutet & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Methotrexate for Prevention of Cardiovascular Events.
Journal ArticleDOI
Concurrent Oral 1 – Therapy of rheumatic disease OP4. Effectiveness of Rituximab in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register (BSRBR)
Moetaza M. Soliman,Darren M. Ashcroft,Kath D. Watson,Mark Lunt,Deborah P M Symmons,Kimme L. Hyrich,H. J. Lachmann,P. Quartier,E. Hachulla,M. Gattorno,R. Cartwright,I. Kone-Paut,F. Zulian,E. Weisbarth-Riedel,L. Lepore,J. Hoyer,I. Foeldvari,E. Ramos,K. Leslie,G. Krammer,R. Preiss,E. Incera,J. B. Kuemmerle-Deschner,P. N. Hawkins,Alexander So,M. De Meulemeester,A. Pikhlak,A. E. Yücel,B. Bodalia,J. Kerrane,U. Arulmani,D. Richard,V. Murphy,P. Sallstig,N. Schlesinger,Dimitrios Christidis,Nada Hassan,Sarah Mapplebeck,Bhaskar Dasgupta,Mark C. Genovese,Anthony Sebba,Andrea Rubbert-Roth,Juan J. Scali,Moshe Zilberstein,Emma Vernon,Ronald F van Vollenhoven,Ernest Choy,Beverley White-Alao,Fowzia Ibrahim,Anna Kowalczyk,Patrick Gordon,Alan Hakim,George D. Kitas,David A. Isenberg,Bridget Griffiths,Bryan Lecky,K Chakravarty,John B Winer,Katalin Dankó,Robert G. Cooper,David Scott +60 more
Journal ArticleDOI
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
Marit Stockfelt,Marit Stockfelt,Anna-Carin Lundell,Merete Lund Hetland,Merete Lund Hetland,Mikkel Østergaard,Mikkel Østergaard,Till Uhlig,Marte Schrumpf Heiberg,Espen A Haavardsholm,M. T. Nurmohamed,Jon Lampa,Dan Nordström,Kim Hørslev Petersen,Bjorn Gudbjornsson,Gerdur Gröndal,Jonathan Aldridge,Kerstin Andersson,Kaj Blennow,Kaj Blennow,Henrik Zetterberg,Ronald F van Vollenhoven,Ronald F van Vollenhoven,Anna Rudin,Anna Rudin +24 more
TL;DR: The type I interferon (IFN) gene signature is present in a subgroup of patients with early rheumatoid arthritis (RA) and protein levels of IFNα have not been measured in RA and it is unknown whether they associate with clinical characteristics or treatment effect as discussed by the authors.
Journal ArticleDOI
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset:
Marwa Elkhalifa,Marwa Elkhalifa,Ana Maria Orbai,Laurence S. Magder,Michelle Petri,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Mary Anne Dooley,Ronald F van Vollenhoven,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,J.P. Callen,S. Sam Lim,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks +42 more
TL;DR: In this article, the American College of Rheumatology (ACR) SLE class included anti-beta 2 glycoprotein I IgA as a common isotype of SLE.